focus -WSS

focus

author：focus 2025-09-06 04:15:35 - browse：7881

Adobe

WASHINGTON — The federal government increasingly is scrutinizing Chinese businesses and their interactions with American companies, including in the biotech sector. Chinese biotechnology companies, the thinking goes, could threaten national security by giving the Chinese government access to the genetic and health information of Americans.

Just Wednesday, President Biden issued an executive order aimed at keeping sensitive data, including Americans’ genetic information, out of the hands of adversaries.

But American biotech companies worry they could become collateral damage if the government sloppily targets sanctions. They’re pushing back against legislation that would bar biotech companies from working with some Chinese companies, especially as the government takes aim at WuXi, a Chinese company considered a crucial partner for discovering, testing, and making medicines that has worked with such brands as Pfizer, AstraZeneca, and GSK.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Congress: Prevent baby formula shortages by passing a new bill

focus

WSS

Shingles, which affected Dianne Feinstein, is on the rise

Covid vaccines: Private market messier than government rollout

Bird flu makes raw milk dangerous to consume, mouse study finds

Beyond aggravation: Constipation is an American epidemic

Would Medicare drug price negotiations stall in a shutdown?

Senator probes 340B programs at Cleveland Clinic, Bon Secours

explore

focus

knowledge

Supreme Court strikes down use of affirmative action

Menendez indictment could see pharma lose a key ally

Psychedelics group wrestles with new pharma identity

Did you have Obamacare on your GOP debate bingo card?

Supreme Court strikes down use of affirmative action

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Affirmative action in medical school literally saved lives

Medical students need to learn the potent medicine of empathy

Medicare details structure of new drug price negotiation program

After a drawn out lobbying fight, ARPA

hotspot

Covid vaccines: Private market messier than government rollout

Hospitals need to get ahead of regulations on climate change

Why some fertility treatments produce more boy babies

Ionis has late

Menendez indictment could see pharma lose a key ally

Listen: Who gets the credit for GLP

focus

focus

hotspot

leisure time